{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:22:56Z","timestamp":1761513776484},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.yebeh.2016.01.033","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T07:31:41Z","timestamp":1456990301000},"page":"126-132","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"PA","title":["Analgesic opioid use in a health-insured epilepsy population during 2012"],"prefix":"10.1016","volume":"57","author":[{"given":"A.N.","family":"Wilner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3 Suppl.","key":"10.1016\/j.yebeh.2016.01.033_bb0005","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"issue":"3","key":"10.1016\/j.yebeh.2016.01.033_bb0010","first-page":"249","article-title":"Opioid prescriptions soar: increase in legitimate use as well as abuse","volume":"297","author":"Kuehn","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.yebeh.2016.01.033_bb0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.36076\/ppj.2010\/13\/401","article-title":"Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective","volume":"13","author":"Manchikanti","year":"2010","journal-title":"Pain Physician"},{"issue":"1","key":"10.1016\/j.yebeh.2016.01.033_bb0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2007.64","article-title":"Trends in opioid prescribing by race\/ethnicity for patients seeking care in US emergency departments","volume":"299","author":"Pletcher","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0025","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cgh.2011.08.008","article-title":"Increasing frequency of opioid prescriptions for chronic abdominal pain in US outpatient clinics","volume":"9","author":"Dorn","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.yebeh.2016.01.033_bb0030","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ajem.2014.07.001","article-title":"Trends in opioid analgesic use for headaches in US emergency departments","volume":"32","author":"Mazer-Amirshahi","year":"2014","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.yebeh.2016.01.033_bb0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s12913-014-0563-8","article-title":"Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural adults: a population-based study using 2010 NAMCS data","volume":"14","author":"Prunuske","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0040","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.0000000000001235","article-title":"On the origin of painful somatosensory seizures","volume":"84","author":"Montavont","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1528-1157.1997.tb01733.x","article-title":"Patients' experience of injury as a result of epilepsy","volume":"38","author":"Buck","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0050","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1528-1157.1998.tb01189.x","article-title":"Injuries and death as a consequence of seizures in people with epilepsy","volume":"39","author":"Spitz","year":"1998","journal-title":"Epilepsia"},{"issue":"43","key":"10.1016\/j.yebeh.2016.01.033_bb0055","first-page":"849","article-title":"Comorbidity in adults with epilepsy\u2014United States, 2010","volume":"63","author":"Kadima","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.yebeh.2016.01.033_bb0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1528-1167.2010.02927.x","article-title":"Comorbidities of epilepsy: results from the epilepsy comorbidities and health (EPIC) survey","volume":"52","author":"Ottman","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yebeh.2014.08.131","article-title":"Diagnosis, procedures, drug utilization, comorbidities and cost of health care for people with epilepsy in 2012","volume":"41","author":"Wilner","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yebeh.2013.12.032","article-title":"Common comorbidities in women and men with epilepsy and the relationship between number of comorbidities and health plan paid costs in 2010","volume":"32","author":"Wilner","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0075","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.seizure.2006.03.001","article-title":"Accidents at work among people with epilepsy: results of a European prospective cohort study","volume":"15","author":"Cornaggia","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","article-title":"Epilepsy, osteoporosis and fracture risk\u2014a meta-analysis","volume":"112","author":"Vestergaard","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0085","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/1471-2458-14-352","article-title":"Untying chronic pain: prevalence and societal burden of chronic pain stages in the general population\u2014a cross-sectional survey","volume":"14","author":"Hauser","year":"2014","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.yebeh.2016.01.033_bb0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1526-4637.2011.01075.x","article-title":"Societal costs of prescription opioid abuse, dependence, and misuse in the United States","volume":"12","author":"Birnbaum","year":"2011","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.yebeh.2016.01.033_bb0095","first-page":"32","article-title":"Healthcare costs and nonadherence among chronic opioid users","volume":"17","author":"Leider","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0100","first-page":"1","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.yebeh.2016.01.033_bb0105","first-page":"37","article-title":"Opioid prescription claims among women of reproductive age\u2014United States, 2008\u20132012","volume":"64","author":"Ailes","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.yebeh.2016.01.033_bb0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"Pergolizzi","year":"2008","journal-title":"Pain Pract"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/898493","article-title":"Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study","author":"Fitzcharles","year":"2013","journal-title":"Pain Res Treat"},{"issue":"1","key":"10.1016\/j.yebeh.2016.01.033_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AJP.0b013e3181b99f35","article-title":"Trend in use of opioids for chronic non-cancer pain among individuals with mental health and substance disorders: the TROUP study","volume":"26","author":"Edlund","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.yebeh.2014.01.022","article-title":"A \u201ccall to arms\u201d to address epilepsy and its comorbidities","volume":"34","author":"Jones","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.eplepsyres.2013.12.002","article-title":"Epilepsy beyond seizure: a population-based study of comorbidities","volume":"108","author":"Selassie","year":"2014","journal-title":"Epilepsy Res"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2016.01.033_bb0135","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.59.9_suppl_5.S21","article-title":"Epilepsy after brain insult. Targeting epileptogenesis","volume":"59","author":"Herman","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0140","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.300.6.711","article-title":"Prevalence of chronic pain after traumatic brain injury","volume":"300","author":"Nampiaparampil","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0145","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1001\/archinte.166.19.2087","article-title":"Association between mental health disorders, problem drug use, and regular prescription opioid use","volume":"166","author":"Sullivan","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0150","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.genhosppsych.2009.07.003","article-title":"Trends in long-term opioid therapy for noncancer pain among persons with a history of depression","volume":"31","author":"Braden","year":"2009","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0155","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1370\/afm.1371","article-title":"Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse","volume":"10","author":"Grattan","year":"2012","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0160","series-title":"Atlas of epilepsies","first-page":"1337","article-title":"Common psychiatric comorbidities in epilepsy: epidemiologic, pathogenic and clinical aspects","author":"Kanner","year":"2010"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.yebeh.2004.01.010","article-title":"The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy","volume":"5","author":"Cramer","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yebeh.2012.01.008","article-title":"Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectives","volume":"24","author":"Kanner","year":"2012","journal-title":"Epilepsy Behav"},{"issue":"20","key":"10.1016\/j.yebeh.2016.01.033_bb0175","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","article-title":"Depression and pain comorbidity","volume":"163","author":"Bair","year":"2003","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.yebeh.2016.01.033_bb0180","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jpain.2008.12.007","article-title":"Comorbid chronic pain and depression: who is at risk?","volume":"10","author":"Miller","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0190","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.yebeh.2003.07.003","article-title":"Epilepsy and migraine","volume":"4","author":"Bigal","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0195","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","volume":"74","author":"Swegle","year":"2006","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.yebeh.2016.01.033_bb0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am J Addict"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0205","first-page":"S276","article-title":"Opioid pharmacokinetic drug\u2013drug interactions","volume":"17","author":"Overholser","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.yebeh.2016.01.033_bb0210","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1176\/appi.ajp.2014.13111526","article-title":"Potentiation of the effect of buprenorphine\/naloxone with gabapentin or quetiapine","volume":"171","author":"Reeves","year":"2014","journal-title":"Am J Psychiatry"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T19:01:07Z","timestamp":1718391667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505016000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":41,"alternative-id":["S1525505016000561"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.01.033","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesic opioid use in a health-insured epilepsy population during 2012","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}